- Home
- GPUS vs NKGN Comparison
GPUS vs NKGN Comparison
Compare GPUS & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- NKGN
- Stock Information
- Founded
- GPUS 1969
- NKGN 2017
- Country
- GPUS United States
- NKGN United States
- Employees
- GPUS N/A
- NKGN N/A
- Industry
- GPUS
- NKGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPUS
- NKGN Health Care
- Exchange
- GPUS NYSE
- NKGN Nasdaq
- Market Cap
- GPUS 8.7M
- NKGN 9.5M
- IPO Year
- GPUS 1996
- NKGN N/A
- Fundamental
- Price
- GPUS $0.18
- NKGN $0.26
- Analyst Decision
- GPUS
- NKGN
- Analyst Count
- GPUS 0
- NKGN 0
- Target Price
- GPUS N/A
- NKGN N/A
- AVG Volume (30 Days)
- GPUS 1.1M
- NKGN 1.7M
- Earning Date
- GPUS 11-26-2024
- NKGN 11-19-2024
- Dividend Yield
- GPUS N/A
- NKGN N/A
- EPS Growth
- GPUS N/A
- NKGN N/A
- EPS
- GPUS N/A
- NKGN N/A
- Revenue
- GPUS $154,192,000.00
- NKGN N/A
- Revenue This Year
- GPUS N/A
- NKGN N/A
- Revenue Next Year
- GPUS N/A
- NKGN N/A
- P/E Ratio
- GPUS N/A
- NKGN N/A
- Revenue Growth
- GPUS 0.56
- NKGN N/A
- 52 Week Low
- GPUS $0.18
- NKGN $0.20
- 52 Week High
- GPUS $3.17
- NKGN $4.06
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- NKGN 43.75
- Support Level
- GPUS N/A
- NKGN $0.23
- Resistance Level
- GPUS N/A
- NKGN $0.29
- Average True Range (ATR)
- GPUS 0.00
- NKGN 0.03
- MACD
- GPUS 0.00
- NKGN 0.01
- Stochastic Oscillator
- GPUS 0.00
- NKGN 36.92
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.
About NKGN NKGen Biotech Inc.
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.